Clinical Trial Update: Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism [NA]

View source ↗

Summary

Clinical trial completed evaluating fondaparinux as monotherapy for deep vein thrombosis and pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Deep Vein Thrombosis, Pulmonary Embolism | NA | Status: COMPLETED